Clinical benefit of mirvetuximab soravtansine in ovarian cancer patients with high folate receptor alpha expression: Results from the SORAYA Study Meeting Abstract
| Authors: | Coleman, R. L.; Matulonis, U.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. R.; Harter, P.; Murphy, C.; Wang, J. Z.; Noble, E.; Esteves, B.; Method, M. |
| Abstract Title: | Clinical benefit of mirvetuximab soravtansine in ovarian cancer patients with high folate receptor alpha expression: Results from the SORAYA Study |
| Meeting Title: | IGCS 2022 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Sep 29-Oct 1 |
| Meeting Location: | New York, NY |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2022-12-01 |
| Start Page: | A18 |
| Language: | English |
| ACCESSION: | WOS:000899252300029 |
| DOI: | 10.1136/ijgc-2022-igcs.30 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O028/#376 -- Source: Wos |
